pharmacy profit

Trump Executive Order on Drug Pricing: What It Really Means for Your Pharmacy

Leave a Comment / KPI Optimization

Let’s be honest—most presidential press conferences don’t get pharmacy owners’ hearts racing. But this one? This one… announcing the Trump Executive Order on prescription drug pricing, dropped some jaws. President Trump’s latest executive order on prescription drug pricing may have just cracked the door open for the biggest shakeup we’ve seen in decades. From cutting […]

Trump Executive Order on Drug Pricing: What It Really Means for Your Pharmacy Read More »

503B pharmacy dispensing for pharmacy profit

Pharmacy Owners It’s Time To Get Fired Up About 503B Pharmacy Dispensing

Leave a Comment / Cash Based Revenue

If you’re like most pharmacy owners, you probably dipped your toe into the world of 503B pharmacy dispensing when compounded GLP-1s like semaglutide and tirzepatide started flying off the shelves. But here’s the thing—if you stopped there, you’re leaving a mountain of cash on the table. Dispensing sterile compounded prescriptions from 503B outsourcing facilities isn’t

Pharmacy Owners It’s Time To Get Fired Up About 503B Pharmacy Dispensing Read More »

should you continue compounding glp1s

Should Pharmacies Keep Compounding GLP1s?

Leave a Comment / Cash Based Revenue

Should You Keep Compounding GLP1s (Tirzepatide or Semaglutide) After the FDA Deadline? Here’s My Take. Howdy pharmacy peeps… Let’s have a real talk about compounding GLP1s. There’s been a lot of chatter lately in the pharmacy world—forums, Facebook groups, emails, even conference hallways—about whether pharmacies should keep compounding GLP1s tirzepatide/semaglutide once the FDA deadlines pass.

Should Pharmacies Keep Compounding GLP1s? Read More »

pharmacy cash flow

Pharmacy Cash Flow Pain Remains Even After The End Of The DIR Fee Apocalypse

Leave a Comment / KPI Optimization

Pharmacy cash flow is still struggling even after the end of the DIR Fee Apocalypse DIR fees: the three letters that have kept pharmacy owners awake at night for years. Now that the so-called “DIR Fee Apocalypse” has come and gone, you might be thinking, “Finally, some relief!” But if you’re anything like most independent

Pharmacy Cash Flow Pain Remains Even After The End Of The DIR Fee Apocalypse Read More »

pharmacy growth tricks

Pharmacy Growth Tricks: Double Your Pharmacy Success in 2025

Leave a Comment / KPI Optimization

I’m a pharmacy growth nerd. I’ve built businesses, consulted for pharmacies across the country, and helped owners take control of their profitability. If there’s a goal that can help your pharmacy thrive, you better believe I’m all over it. Because goals are the fastest way to bridge the gap between where your pharmacy is today

Pharmacy Growth Tricks: Double Your Pharmacy Success in 2025 Read More »

semaglutide & tirzepatide

Semaglutide & Tirzepatide Patent Considerations

Leave a Comment / Cash Based Revenue

The Legal Landscape of Semaglutide & Tirzepatide: What Pharmacy Owners Need to Know If you’ve been watching the ongoing saga of compounded GLP-1 medications, you already know that the semaglutide and tirzepatide situations are heating up. Between Novo Nordisk’s and Eli Lilly’s patent protections, FDA rulings, and lawsuits flying around, pharmacy owners need to stay

Semaglutide & Tirzepatide Patent Considerations Read More »

Best of KPI

KPI Optimization In Independent Pharmacy: Top 5 Blogs From 2024

Leave a Comment / KPI Optimization

KPI optimization is critical to improving the performance of your independent pharmacy. If you don’t measure it, you can’t improve it—this statement has never been truer for pharmacy owners. Key Performance Indicators (KPIs) are the benchmarks of success, providing insights into your pharmacy’s performance and guiding smarter decisions. Yet, many pharmacy owners overlook this critical

KPI Optimization In Independent Pharmacy: Top 5 Blogs From 2024 Read More »

pbm

The Pharmacy Owner’s Guide to Navigating PBM Headaches in 2025

Leave a Comment / PBM Optimization

PBM headaches will still be around in 2025. Get your guide to making them just a wee bit better. PBM—those three little letters have caused more headaches for independent pharmacy owners than we care to count. Just when you think you’ve figured out their latest reimbursement trick, they hit you with another clawback, new DIR

The Pharmacy Owner’s Guide to Navigating PBM Headaches in 2025 Read More »

Scroll to Top